top of page

U.S. Trade Development Agency And 19Labs Partner to Accelerate Rural Telemedicine Deployments Throughout Mexico

The USTDA-funded study, led by 19Labs together with our Mexican partner, Vasanta, will enable rural community members to receive advanced healthcare through the GALE telemedicine platform and our partners Zoom, Viasat, Echonous, and others.


Redwood City, CA – January 8, 2024


Left to Right: Bernardo Vasquez, Vice President of Vasanta, Enoh T. Ebong, Director of USTDA, and Ram Fish, CEO of 19Labs, during the signing of the USTDA-Sponsored Study of Rural Telemedicine in Mexico
Left to Right: Bernardo Vasquez, Vice President of Vasanta, Enoh T. Ebong, Director of USTDA, and Ram Fish, CEO of 19Labs, during the signing of the USTDA-Sponsored Study of Rural Telemedicine in Mexico

Today, the U.S. Trade and Development Agency announced that it has signed a grant agreement with Mexican digital connectivity company Vasanta Comunicaciones SAPI de CV (Vasanta) that will pilot telemedicine technology from California-based 19Labs, Inc. (19Labs) in rural southern Mexico. This feasibility study and pilot project will help develop a roadmap to scale the implementation of high-quality, sustainable telemedicine clinics to 1,000 rural communities across Mexico.

 

“This project is a great example of the kind of healthcare infrastructure that we want to support. It highlights the value of U.S. innovation, it is transformational, and it will save lives,” said Enoh T. Ebong, USTDA’s Director. “We look forward to seeing how this partnership materializes into greater healthcare access for the people of Mexico.”

The USTDA-funded pilot project will support the deployment of 50 rural telemedicine clinics in the States of Oaxaca and Tabasco. 19Labs will contribute its telemedicine technology, and Vasanta will provide the required digital connectivity for the clinics. The roadmap for scaling the project’s implementation will include a technical and economic analysis, financing plan, and social impact assessment.

 

“Vasanta is proud to partner with USTDA and 19Labs to deliver innovative healthcare solutions in Mexico,” said Bernardo Vasquez, Vice President of Vasanta. “Vasanta is eager to provide the critical backbone connectivity that will support healthcare services that can meet the medical needs of rural communities in Mexico.”

GALE eClinics bring together smart, advanced diagnostic tools and cutting-edge technologies, such as video conferencing by Zoom, ultrasound capabilities from EchoNous, and satellite connectivity from ViaSat

"Our commitment is to bridge the gaps in high-quality healthcare in rural communities through innovative technologies," expressed Ram Fish, CEO of 19Labs. "The USTDA's grant is pivotal—it not only assists in establishing the effectiveness of our telemedicine clinics in Mexico but will also propel our nationwide deployment strategy and extend the reach of our program beyond its borders, marking a significant leap towards global healthcare accessibility."

About 19Labs

19Labs is the creator of GALE, a Next Generation Point-of-Care platform for pharmacies, schools, workplaces, and rural communities. GALE brings together cutting-edge diagnostic technologies from industry leaders like Zoom, Elo, Amwell, Samsung Mobile, MIR, Omron, Viasat, EchoNous, PAP Link, and many others in one smart, efficient, and cost-effective platform. It was designed from the ground up to be operated by non-healthcare professionals in locations with limited infrastructure and optimized for low bandwidth and intermittent connectivity. To learn more about GALE, please visit www.19labs.com.


About the USTDA

The U.S. Trade and Development Agency helps companies create U.S. jobs through the export of U.S. goods and services for priority infrastructure projects in emerging economies.  USTDA links U.S. businesses to export opportunities by funding project preparation and partnership building activities that develop sustainable infrastructure and foster economic growth in partner countries.

Comments

Couldn’t Load Comments
It looks like there was a technical problem. Try reconnecting or refreshing the page.
bottom of page